These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 227611)

  • 1. [Revaccination with Sabin's poliovaccine type 3 (author's transl)].
    Srámová H; Teplý V; Svandová E
    Cesk Epidemiol Mikrobiol Imunol; 1979 Jul; 28(4):201-6. PubMed ID: 227611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Revaccination by oral monovalent poliovaccine type 3 (author's transl)].
    Srámová H; Teplý V; Bernatziková V
    Cesk Epidemiol Mikrobiol Imunol; 1981 Mar; 30(2):95-100. PubMed ID: 6261973
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comment on the contribution by Pietsch, R., H. Riegel: Implementation of poliomyelitis revaccination].
    Dittmann S; Koch MA; Diedrich S; Maass G; Böthig B
    Gesundheitswesen; 1993 Jul; 55(7):381-3. PubMed ID: 8396469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comment on the contribution by R. Pietsch and H. Riegel: "Implementation of poliomyelitis revaccination"].
    Volkmer KJ; Kröger E
    Gesundheitswesen; 1993 Jul; 55(7):380. PubMed ID: 8396468
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of two schedules for administering trivalent oral poliovaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1985 Sep; 19(5):275-7. PubMed ID: 3004841
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of oral poliovaccine in infancy.
    Pangi NS; Master JM; Dave KH
    Indian Pediatr; 1977 Jul; 14(7):523-8. PubMed ID: 200558
    [No Abstract]   [Full Text] [Related]  

  • 7. Herd immunity to poliovirus in Dundee.
    Smith WC; Small RG; Dunkerley RA; Green DM
    Health Bull (Edinb); 1982 Nov; 40(6):296-305. PubMed ID: 6298147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Implementing secondary poliomyelitis vaccination].
    Pietsch R; Riegel H
    Gesundheitswesen; 1992 Dec; 54(12):714-5. PubMed ID: 1366256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Response of revaccination against polio I in seronegative children after receiving 3 or more doses of the vaccine].
    Ruiz-Gómez J; Sánchez Burgos Y; Arrayales Sandoval F; Velázquez Zúñiga C
    Gac Med Mex; 1977 Jan; 113(1):23-7. PubMed ID: 863152
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliovirus antibody status after vaccination with trivalent oral vaccine.
    Clara R; Deprettere A; van der Berghe D; Pattyn S
    Acta Paediatr Belg; 1976; 29(4):245-51. PubMed ID: 192040
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with oral poliovirus vaccine in China.
    Dong DX
    Prog Med Virol; 1985; 31():212-21. PubMed ID: 2982175
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of poliovirus neutralizing antibodies in young adult women.
    Mayer TR; Balfour HH
    JAMA; 1981 Sep; 246(11):1207-9. PubMed ID: 6267329
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preventive poliomyelitis immunization].
    Böthig B
    Z Arztl Fortbild (Jena); 1990; 84(8):365-7. PubMed ID: 2165712
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behaviour and properties of poliomyelitis coproantibodies using the "antiglobin test" and the conventional neutralisation test (author's transl)].
    Albano A; De Donato S; Scarinci V; Jakschik M
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(1):1-11. PubMed ID: 4152333
    [No Abstract]   [Full Text] [Related]  

  • 17. [Humoral antibodies, coproantibodies and viral excretion in newborn infants immunized with poliomyelitis vaccine].
    Ruíz-Gómez J; Caloca García MA; Longega Escobio P
    Salud Publica Mex; 1979; 21(2):127-34. PubMed ID: 231330
    [No Abstract]   [Full Text] [Related]  

  • 18. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 20. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.